Back to Resource Hub Article

eCOA Consortium's Guide to Implementing Sensor-based DHTs in Trials

Published in Clinical and Translational Science (CTS), November 2024, Official journal of ASCPT (American Society for Clinical Pharmacology and Therapeutics)
Authored by researchers from the eCOA Consortium

Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA Consortium

This comprehensive review provides a practical framework for successfully deploying sensor-based DHTs in clinical trials. Drawing from collective experience and literature, the authors present five key implementation areas: sensor selection strategy, participant data sharing practices, multi-stakeholder input, diversity considerations, and site training approaches. The paper addresses the critical challenge of participant compliance by offering specific, evidence-based recommendations to balance scientific needs with participant burden. For researchers and sponsors, this guide helps navigate common pitfalls and optimize DHT deployment to enhance data quality while minimizing participant and site burden.

Discover the eCOA Consortium's evidence-based framework for optimizing digital health technology implementation in clinical trials—practical solutions that balance scientific rigor with participant experience.

Similar posts

Looking for more insights? Explore related resources.

ARTICLE

ACT: Utilizing DHTs for Clinical Trial Endpoints

READ THE ARTICLE
WHITE PAPER

Digital Health Technologies (DHTs) in Clinical Trials: Key Points from the FDA’S Important Draft Guidance

READ THE PAPER
BROCHURE

Signant Health Corporate Overview

SEE THE BROCHURE

Get notified on new marketing insights

Here mention the benefits of subscribing